Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04965012
Status:
COMPLETED
Last Update Posted:
2023-12-01
First Post:
2021-07-06
Brief Title:
Testing the Efficacy of an Online Treatment Program for Heavy Cannabis Use
Sponsor:
York University
Organization:
York University
Study Overview
Official Title:
Testing the Efficacy of an Online Evidence-Based Treatment for Heavy Cannabis Use in Canadian Adults A Randomized Controlled Trial RCT
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cannabis is a frequently-used psychoactive substance While the majority of individuals can use cannabis without experiencing problems a small minority of people develop cannabis problems Despite the small-to-medium reported effect sizes of cognitive behavioural therapy CBT and motivational enhancement therapy MET treatments for cannabis misuse many cannabis users do not seek treatment Online CBTMET programs have the potential to be cost-effective and accessible and offer a less stigmatizing option for treatment These programs may also help capture cannabis users who experience subclinical problems who are not captured by traditional treatment Existing treatment programs also need to be adapted to maximize participant retention and increase treatment completion as many current cannabis use treatment programs have significant drop-out rates Hence the goal of the proposed randomized controlled trial RCT is to examine the efficacy of an online evidence-based CBTMET treatment program Outcomes of a combined CBTMET treatment program will be compared to a CBT-only treatment program and a waitlist control This research will provide insight into the novel contribution of MET to online CBT treatment programs for cannabis misuse
The researchers are hoping to recruit 303 participants for this study from Central and Eastern Canada Participants will be randomly assigned to one of the treatment groups ie CBT with MET CBT without MET or the psychoeducational control group Individuals in either treatment group will be given 6 weeks to work through 8 online modules Throughout the modules participants will identify goals related to cannabis use learn strategies to cope with cannabis cravings triggers and social pressures and learn to prevent relapse Participants randomly assigned to the control ie psychoeducation will receive links to websites that provide general psychoeducation about cannabis use and wellbeing All participants will complete online assessment measures at baseline end of treatment and at follow up approximately one month later ie 0 weeks 6 weeks 10 weeks in order to assess the efficacy of the treatment At the end of the study individuals in the control group will be given access to the CBT without MET treatment
The researchers are hoping to recruit 303 participants for this study from Central and Eastern Canada Participants will be randomly assigned to one of the treatment groups ie CBT with MET CBT without MET or the psychoeducational control group Individuals in either treatment group will be given 6 weeks to work through 8 online modules Throughout the modules participants will identify goals related to cannabis use learn strategies to cope with cannabis cravings triggers and social pressures and learn to prevent relapse Participants randomly assigned to the control ie psychoeducation will receive links to websites that provide general psychoeducation about cannabis use and wellbeing All participants will complete online assessment measures at baseline end of treatment and at follow up approximately one month later ie 0 weeks 6 weeks 10 weeks in order to assess the efficacy of the treatment At the end of the study individuals in the control group will be given access to the CBT without MET treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None